Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis

Fluids and Barriers of the CNS

Volumn 8, Issue 1, 2011, Pages

  Ehling, Rainer ^a   Pauli, Franziska Di ^a   Lackner, Peter ^a   Kuenz, Bettina ^a   Santner, Wolfram ^a   Lutterotti, Andreas ^a   Gneiss, Claudia ^a   Hegen, Harald ^a   Schocke, Michael ^a   Deisenhammer, Florian ^a   Berger, Thomas ^a   Reindl, Markus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Blood csf barrier (BCSFB); Central nervous system (CNS); Cerebrospinal fluid (CSF); Fibrinogen; Neuroinflammation

Indexed keywords

ALBUMIN; FIBRINOGEN; GADOLINIUM PENTETATE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL MENINGOENCEPHALITIS; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CYTOLOGY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; GUILLAIN BARRE SYNDROME; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LABORATORY TEST; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MENINGOENCEPHALITIS; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROLOGIC DISEASE; NEURORADIOLOGY; NON INFLAMMATORY NEUROLOGICAL CONTROL; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; VIRUS MENINGITIS; VIRUS MENINGOENCEPHALITIS;

EID: 84862176848     PISSN: None     EISSN: 20458118     Source Type: Journal    
DOI: 10.1186/2045-8118-8-25     Document Type: Article

References (17)

1. Doolittle RF, Spraggon G, Everse SJ. Three-dimensional structural studies on fragments of fibrinogen and fibrin. Curr Opin Struct Biol 1998, 8:792-798. 10.1016/S0959-440X(98)80100-0, 9914253.
2. Francis CW, Sporn LA, Arvan DS, Collichio FA, Marder VJ. Megakaryocyte and hepatocyte origins of human fibrinogen biosynthesis exhibit hepatocyte-specific expression of gamma chain-variant polypeptides. Blood 1989, 74:743-750.
3. Kamath S, Lip GY. Fibrinogen: biochemistry, epidemiology and determinants. QJM 2003, 96:711-729. 10.1093/qjmed/hcg129, 14500858.
4. Schisano G, Franco A, Nina P, Papa ML, Iannuzzi M, De Biase R, Caldora M. Monitoring of fibrin and fibrinogen degradation products (FDP) in the cerebrospinal fluid of patients with subarachnoid haemorrhage due to ruptured aneurysm. Report of 55 cases. J Neurosurg Sci 1994, 38:77-86.
5. Conti A, Sanchez-Ruiz Y, Bachi A, Beretta L, Grandi E, Beltramo M, Alessio M. Proteome study of human cerebrospinal fluid following traumatic brain injury indicates fibrin(ogen) degradation products as trauma-associated markers. J Neurotrauma 2004, 21:854-763. 10.1089/0897715041526212, 15307898.
6. Zhang HL, Zhang XM, Mao XJ, Deng H, Li HF, Press R, Fredrikson S, Zhu J. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Acta Neurol Scand 2011,
7. Adams RA, Passino M, Sachs BD, Nuriel T, Akassoglou K. Fibrin mechanisms and functions in nervous system pathology. Mol Interv 2004, 4:163-176.
8. Claudio L, Raine CS, Brosnan CF. Evidence of persistent bloodbrain barrier abnormalities in chronic- progressive multiple sclerosis. Acta Neuropathol 1995, 90:228-238. 10.1007/BF00296505, 8525795.
9. Paterson PY. Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats. Fed Proc 1976, 35:2428-2434.
10. Adams RA, Bauer J, Flick MJ, Sikorski SL, Nuriel T, Lassmann H, Degen JL, Akassoglou K. The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med 2007, 204:571-582. 10.1084/jem.20061931, 2137908, 17339406.
11. Jennett B, Bond M. Assessment of outcome after severe brain damage. A practical scale. Lancet 1975, 1:480-484.
12. de Gans J, van de Beek D, . European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002, 347:1549-1556. 10.1056/NEJMoa021334, 12432041, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators.
13. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol 1998, 44:780-788. 10.1002/ana.410440512, 9818934.
14. Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet 1978, 2:750-753.
15. Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, Rauer S, Sellebjerg F, . EFNS Task Force Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol 2006, 13:913-922. 10.1111/j.1468-1331.2006.01493.x, 16930354, EFNS Task Force.
16. Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, Aloisi F, Reynolds R. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010, 68:477-493. 10.1002/ana.22230, 20976767.
17. Ryu JK, Davalos D, Akassoglou K. Fibrinogen signal transduction in the nervous system. J Thromb Haemost 2009, 7(Suppl 1):151-154. 2888044, 19630789.